If you or someone you know has diabetes, you’ve likely heard of metformin, a drug that’s primarily prescribed to support better blood sugar regulation. But did you know that metformin is also a ...
Metformin is the most widely prescribed drug in the world to treat Type 2 diabetes, and it's been around for more than 60 years. But now, researchers are learning more about this popular medicine's ...
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...
Patients with both heart failure and type 2 diabetes who are treated with a metformin-based strategy have a lower mortality risk than matched individuals not treated with anti-diabetic drugs, new ...
Please provide your email address to receive an email when new articles are posted on . Women with gestational diabetes who received metformin had lower fasting glucose than those who received placebo ...
Metformin showed promise for improving the overall survival rate of patients with melanoma; however, this result may be an indirect consequence of the drug. “Based on the progress of research on new ...
Metformin treatment in patients with type 2 diabetes who have historical contraindications to the drug's use is associated with improved clinical outcomes, new research shows. Matthew J Crowley, MD, ...
Early metformin initiation after COVID-19 infection is associated with a substantially lower 1-year risk for long COVID in adults with overweight or obesity, according to study results published in ...
A UK study reveals that metformin, India's most prescribed diabetes medication, may slash the risk of Long COVID by 64%.
Veterans who developed type 2 diabetes and who were started on monotherapy with metformin rather than a sulfonylurea had a lower risk of dying up to 6 years later — whether their kidney function was ...
With the COVID pandemic approaching the end of its fifth year, the ninth major wave of infections is washing across the global population infecting tens of millions of people each day. The return to ...